Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1006065생성일: 2026년 10월 26일
Trifluoroacetic acid → N-(2-(3-methoxyphenyl) ethyl)-4-(2-ethyl-5-methoxy-benzyl)piperidine Hydrochloride
https://huagongshe.com/reaction/1006065
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Trifluoroacetic acid | HCID 6422 | — |
| 반응물 | Triethylsilane | HCID 12052 | — |
| 반응물 | Triethylsilanol | HCID 69005 | — |
| 반응물 | Sodium Bicarbonate | HCID 516892 | — |
| 반응물 | Ether hydrochloride | HCID 10953452 | — |
| 반응물 | N-(2-(3-methoxyphenyl)ethyl)-4-(2-(1-hydroxyethyl)-5-methoxybenzyl)piperidine | HCID 22675304 | — |
| 반응물 | N-(2-(3-methoxyphenyl)ethyl)-4-(2-ethyl-5-methoxybenzyl)piperidine | HCID 22675314 | — |
| 용매 | Diethyl Ether | HCID 3283 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 용매 | Ethyl Acetate | HCID 8857 | — |
| 생성물 | N-(2-(3-methoxyphenyl) ethyl)-4-(2-ethyl-5-methoxy-benzyl)piperidine Hydrochloride | HCID 22675313 | 79.6% |
반응 단계
Trifluoroacetic acid (0.5 ml) was added dropwise to a solution of N-(2-(3-methoxyphenyl)ethyl)-4-(2-(1-hydroxyethyl)-5-methoxybenzyl)piperidine (250 mg, 0.65 mmol) and triethylsilane (91 mg, 0.78 mmol) in dichloromethane (5 ml) under ice-cooling, and the reaction mixture was stirred as it was for 2 hours. Ethyl acetate and a saturated aqueous sodium hydrogencarbonate solution were added thereto to effect separation, and the organic layer was washed with a saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, and then distilled under reduced pressure to remove the solvent. The residue was purified by a silica gel column chromatography (chloroform/methanol=50/1) to obtain a mixture of N-(2-(3-methoxyphenyl)ethyl)-4-(2-ethyl-5-methoxybenzyl)piperidine and triethylsilanol. This mixture was dissolved in dichloromethane (5 ml), followed by adding thereto a 1N hydrogen chloride-diethyl ether solution (1 ml, 1 mmol), and the solvent was distilled off under reduced pressure. The residue was suspended in diethyl ether and the precipitate was collected by filtration and washed with diethyl ether to obtain the title compound (209 mg, 79%) as white powder.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06787560B2 |
|---|
| 출처 데이터셋 | uspto-grants-2004_09 |
|---|
| ORD ID | ord-32603b56029e4efabf3f59675f734cf0 |
|---|
| 출처 메모 | uspto-grants-2004_09 |
|---|